Display options
Share it on

Front Genet. 2014 Jun 11;5:174. doi: 10.3389/fgene.2014.00174. eCollection 2014.

Evaluation of the Schistosoma mansoni Y-box-binding protein (SMYB1) potential as a vaccine candidate against schistosomiasis.

Frontiers in genetics

Sílvia R C Dias, Mariana Boroni, Elizângela A Rocha, Thomaz L Dias, Daniela de Laet Souza, Fabrício M S Oliveira, Mainá Bitar, Andrea M Macedo, Carlos R Machado, Marcelo V Caliari, Glória R Franco

Affiliations

  1. Departamento de Bioquímica e Imunologia, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.
  2. Departamento de Patologia Geral, Instituto de Ciências Biológicas, Universidade Federal de Minas Gerais Belo Horizonte, Brazil.

PMID: 24966869 PMCID: PMC4052899 DOI: 10.3389/fgene.2014.00174

Abstract

Schistosomiasis is a neglected tropical disease, and after malaria, is the second most important tropical disease in public health. A vaccine that reduces parasitemia is desirable to achieve mass treatment with a low cost. Although potential antigens have been identified and tested in clinical trials, no effective vaccine against schistosomiasis is available. Y-box-binding proteins (YBPs) regulate gene expression and participate in a variety of cellular processes, including transcriptional and translational regulation, DNA repair, cellular proliferation, drug resistance, and stress responses. The Schistosoma mansoni ortholog of the human YB-1, SMYB1, is expressed in all stages of the parasite life cycle. Although SMYB1 binds to DNA or RNA oligonucleotides, immunohistochemistry assays demonstrated that it is primarily localized in the cytoplasm of parasite cells. In addition, SMYB1 interacts with a protein involved in mRNA processing, suggesting that SMYB1 functions in the turnover, transport, and/or stabilization of RNA molecules during post-transcriptional gene regulation. Here we report the potential of SMYB1 as a vaccine candidate. We demonstrate that recombinant SMYB1 stimulates the production of high levels of specific IgG1 antibodies in a mouse model. The observed levels of specific IgG1 and IgG2a antibodies indicate an actual protection against cercariae challenge. Animals immunized with rSMYB1 exhibited a 26% reduction in adult worm burden and a 28% reduction in eggs retained in the liver. Although proteins from the worm tegument are considered optimal targets for vaccine development, this study demonstrates that unexposed cytoplasmic proteins can reduce the load of intestinal worms and the number of eggs retained in the liver.

Keywords: SMYB1; Schistosoma mansoni; Y-box-binding protein 1; cytoplasmic antigen; vaccine candidates

References

  1. Arthritis Res Ther. 2005;7(6):R1360-74 - PubMed
  2. Parasitol Today. 2000 Nov;16(11):497-501 - PubMed
  3. Vaccine. 2001 Dec 12;20(5-6):724-30 - PubMed
  4. Immunol Rev. 1999 Oct;171:149-61 - PubMed
  5. J Mol Biol. 1999 Sep 24;292(3):741-58 - PubMed
  6. Vaccine. 2004 Jan 2;22(3-4):503-10 - PubMed
  7. Arch Virol. 2011 Feb;156(2):183-202 - PubMed
  8. Mol Biochem Parasitol. 2004 May;135(1):21-30 - PubMed
  9. EMBO Rep. 2009 Jul;10(7):783-9 - PubMed
  10. Parasitology. 2013 Aug;140(9):1085-95 - PubMed
  11. Trends Cell Biol. 1998 Aug;8(8):318-23 - PubMed
  12. J Mol Biol. 2000 Jul 21;300(4):1005-16 - PubMed
  13. Immunome Res. 2006 Apr 24;2:2 - PubMed
  14. Immunogenetics. 2005 Apr;57(1-2):33-41 - PubMed
  15. J Biol Chem. 2003 Oct 31;278(44):43470-9 - PubMed
  16. Acta Trop. 2008 Nov-Dec;108(2-3):256-62 - PubMed
  17. Parasitol Today. 1997 Nov;13(11):438-43 - PubMed
  18. Nat Rev Immunol. 2003 Jan;3(1):73-8 - PubMed
  19. Bioessays. 2010 Feb;32(2):109-18 - PubMed
  20. OMICS. 2011 Sep;15(9):567-77 - PubMed
  21. Anal Biochem. 1976 May 7;72:248-54 - PubMed
  22. J Biol Chem. 1995 Feb 24;270(8):3527-33 - PubMed
  23. Nucleic Acids Res. 2013 Jan;41(Database issue):D43-7 - PubMed
  24. Gene. 1997 Oct 1;198(1-2):5-16 - PubMed
  25. Acta Biochim Biophys Sin (Shanghai). 2005 Nov;37(11):751-8 - PubMed
  26. Nucleic Acids Res. 2011 Jan;39(Database issue):D225-9 - PubMed
  27. Bull World Health Organ. 1968;39(2):328-31 - PubMed
  28. Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W327-31 - PubMed
  29. Parasitology. 1965 Nov;55(4):695-700 - PubMed
  30. J Mol Biol. 2004 Mar 26;337(3):635-45 - PubMed
  31. J Exp Med. 1994 May 1;179(5):1605-11 - PubMed
  32. Nat Methods. 2011 Sep 29;8(10):785-6 - PubMed
  33. Protein Eng Des Sel. 2004 Apr;17(4):349-56 - PubMed
  34. Acta Trop. 2002 May;82(2):183-92 - PubMed
  35. Rev Soc Bras Med Trop. 1999 Nov-Dec;32(6):705-11 - PubMed
  36. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):464-71 - PubMed
  37. Biochemistry (Mosc). 2011 Dec;76(13):1402-33 - PubMed
  38. Annu Rev Genomics Hum Genet. 2009;10:211-40 - PubMed
  39. J Mol Biol. 1999 Dec 17;294(5):1351-62 - PubMed
  40. PLoS One. 2010 Apr 01;5(4):e9931 - PubMed
  41. J Parasitol. 2013 Apr;99(2):194-202 - PubMed
  42. PLoS Negl Trop Dis. 2008 Oct 01;2(10):e308 - PubMed
  43. Mem Inst Oswaldo Cruz. 1987 Jan-Mar;82(1):73-9 - PubMed
  44. Immunol Rev. 2004 Oct;201:156-67 - PubMed
  45. Immunol Rev. 2011 Jan;239(1):237-70 - PubMed
  46. Parasite Immunol. 2008 Apr;30(4):215-21 - PubMed
  47. Drug Discov Today. 2009 May;14(9-10):472-8 - PubMed
  48. Parasite Immunol. 2012 May;34(5):276-84 - PubMed
  49. PLoS One. 2014 Jan 21;9(1):e85401 - PubMed
  50. J Biol Chem. 1992 Jul 15;267(20):13799-802 - PubMed
  51. J Biol Chem. 2003 Feb 14;278(7):5156-62 - PubMed
  52. Dev Biol. 1998 Sep 15;201(2):217-29 - PubMed
  53. J Virol. 1985 Sep;55(3):836-9 - PubMed
  54. Mol Biochem Parasitol. 2002 Nov-Dec;125(1-2):47-57 - PubMed
  55. J Mol Genet Med. 2005 Aug 03;1(1):11-7 - PubMed
  56. FEBS Lett. 1997 Nov 17;417(3):390-4 - PubMed
  57. Mem Inst Oswaldo Cruz. 2006 Sep;101 Suppl 1:13-20 - PubMed
  58. Nat Rev Microbiol. 2010 Nov;8(11):814-26 - PubMed
  59. Infect Immun. 2004 Jun;72(6):3336-43 - PubMed
  60. J Immunol. 1996 Jul 15;157(2):806-14 - PubMed
  61. Bioinformatics. 2001 Sep;17(9):847-8 - PubMed
  62. Cell Cycle. 2006 Jun;5(11):1143-7 - PubMed
  63. Arthritis Rheum. 2009 Nov;60(11):3465-75 - PubMed
  64. Eur J Cell Biol. 2012 Jun-Jul;91(6-7):567-75 - PubMed
  65. Clin Microbiol Rev. 2008 Jan;21(1):225-42 - PubMed
  66. Lancet Infect Dis. 2006 Jul;6(7):411-25 - PubMed
  67. FASEB J. 2004 Aug;18(11):1169-75 - PubMed
  68. Trans R Soc Trop Med Hyg. 2002 Sep-Oct;96(5):465-9 - PubMed
  69. Bioessays. 2003 Jul;25(7):691-8 - PubMed
  70. Nat Rev Immunol. 2002 Jul;2(7):499-511 - PubMed
  71. Trends Parasitol. 2006 Dec;22(12):575-82 - PubMed
  72. Bioessays. 2004 Jul;26(7):752-65 - PubMed
  73. Parasitol Res. 2013 Aug;112(8):2791-803 - PubMed
  74. RNA Biol. 2009 Jan-Mar;6(1):59-64 - PubMed
  75. Acta Trop. 2008 Jun;106(3):162-7 - PubMed
  76. Dev Biol. 2004 Aug 1;272(1):217-30 - PubMed
  77. Nature. 1990 Apr 26;344(6269):823-4 - PubMed
  78. EMBO J. 2013 May 15;32(10):1478-88 - PubMed
  79. Eur J Immunol. 2005 Aug;35(8):2295-303 - PubMed
  80. J Biol Chem. 2011 Feb 11;286(6):4485-92 - PubMed
  81. FASEB J. 1996 Mar;10(4):435-43 - PubMed
  82. Parasit Vectors. 2011 Jun 10;4:103 - PubMed
  83. Nucleic Acids Res. 2004 Jul 1;32(Web Server issue):W321-6 - PubMed
  84. FEBS Lett. 1990 Dec 10;276(1-2):172-4 - PubMed
  85. J Immunol. 1996 Jun 15;156(12):4739-45 - PubMed
  86. J Biol Chem. 1997 Jan 3;272(1):196-202 - PubMed
  87. Immunogenetics. 2010 Jun;62(6):357-68 - PubMed
  88. J Mol Biol. 1990 Oct 5;215(3):403-10 - PubMed
  89. J Clin Invest. 2008 Apr;118(4):1311-21 - PubMed

Publication Types